Ellagic Acid 40%
English English Precision-milled, climate-sealed raw materials tested for immediate solubility, moisture resistance, and continuous maritime distribution across the Pacific Basin.
In modern performance nutrition, functional cardiology, and specialty biopharmaceutics, L-Arginine Nitrate represents a breakthrough fusion molecule. Synthesized through stoichiometric bonding between pharmaceutical-grade L-arginine and inorganic nitric acid (nitrate group), this organic salt overcomes the physiological bioavailability bottlenecks historically associated with conventional L-Arginine base or L-Arginine HCl. While standard L-arginine undergoes heavy first-pass hepatic metabolism by the arginase enzyme, the bound nitrate moiety in L-Arginine Nitrate utilizes an alternate biochemical route: the Nitrate-Nitrite-Nitric Oxide (NO) pathway.
This systemic dual-action mechanism provides rapid and sustained endothelial vasodilation. The L-arginine component activates the classical eNOS (endothelial nitric oxide synthase) pathway requiring molecular oxygen, while the nitrate fraction bypasses eNOS entirely, reducing efficiently under hypoxic or acidic cellular conditions. The result is superior microvascular perfusion, enhanced muscular oxygenation, and regulated mean arterial pressure without inducing rapid cellular tolerance.
| Analytical Parameter | Technical Specification | Test Methodology | Typical Batch Result |
|---|---|---|---|
| Chemical Identification | 1:1 Molar Fusion Salt (L-Arginine Nitrate) | FTIR / Infrared Spectroscopy | Conforms to Molecular Standard |
| Assay (Anhydrous Basis) | ≥ 98.5% to 101.5% | HPLC (High Performance Liquid Chromatography) | 99.34% Pure Compound |
| Appearance & Physical State | White to Off-White Crystalline Powder | Visual & Organoleptic Evaluation | Passes Standard Grade |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 10 ppm Combined (Pb ≤ 1 ppm, As ≤ 1 ppm) | ICP-MS (Plasma Mass Spectrometry) | < 2.5 ppm Total Heavy Metals |
| Loss on Drying (Moisture) | ≤ 0.50% Maximum | Vacuum Desiccation (105°C, 4 Hours) | 0.28% Moisture Retention |
| Microbial Total Plate Count | ≤ 1,000 CFU/g (Yeast & Mold ≤ 100 CFU/g) | USP <61> Microbiological Examination | < 100 CFU/g (Negative for E. coli/Salmonella) |
Strategic deployment of stable nitric oxide precursors within oceanic ecosystems facing distinct logistical and public health considerations.
Across Majuro Atoll and the RMI, non-communicable metabolic and vascular challenges represent significant public health concerns. Integrating stabilized L-Arginine Nitrate into targeted nutritional formulas and community health programs supports microvascular flexibility, mitigates arterial stiffness, and encourages healthy circulatory equilibrium.
Majuro is globally recognized as an international transshipment hub for Pacific tuna longline and purse seine fleets. Marine operators, deep-sea divers, and industrial dock workers endure prolonged physical exertion in high-temperature environments. Dual-pathway nitrate supplementation aids in heat mitigation, minimizes peripheral cramping, and reduces cardiovascular strain.
Due to remote transpacific freight corridors, retail supplements in Majuro frequently suffer from hygroscopic degradation, lumpiness, and loss of efficacy. Our crystal-engineered L-Arginine Nitrate offers superior non-clumping stability when compounded with functional acidulants, making it ideal for compact single-serve sachets and local institutional bottling.
Procuring fine bulk chemicals and active nutraceutical ingredients (APIs) for import into the Port of Majuro requires profound operational understanding of transpacific trade dynamics. With ocean container freight routing frequently through intermediate transshipment ports such as Honolulu, Busan, or Suva, transit lead times can range from 30 to 60 days across equatorial maritime environments characterized by high ambient humidity and saline marine atmospheres.
Consequently, procurement officers and distributors in Majuro are transitioning away from uncertified open-market traders in favor of direct primary manufacturers offering:
Standard craft drums are upgraded to pharmaceutical-grade double-layer polyethylene inner liners, heat-welded aluminum foil vapor barriers, and external reinforced fiber drums with silica active desiccants to prevent caking during Pacific sea voyages.
Complete documentation packages accompanying each ocean bill of lading (B/L), including complete Certificates of Analysis (COA), safety data sheets (SDS conforming to GHS Rev.8), non-animal origin certificates, and phytosanitary clearance documents.
Low minimum order thresholds (starting at 1 kg for formulation pilot validation up to multiple FCL container consignments) that prevent inventory overstocking and cash flow stagnation for private Marshallese distributors.
Combining nearly 15 years of chemical synthesis, botanical extraction, and audited quality management systems.
Our facility in Xi'an is physically verified onsite by SGS Group. We operate dedicated Class 100,000 cleanrooms, vacuum drying chambers, multi-function stainless crystallization reaction vessels, and advanced milling lines ensuring strict zero-cross-contamination.
We operate under certified ISO 9001:2015, ISO 22000, and HACCP quality parameters. For specialty market sectors, our ingredients carry authenticated HALAL, KOSHER, and feed-grade FAMI-QS accreditations, alongside select USDA/EU Organic items.
Never rely on blind supplier declarations. Our in-house analytical testing center features dual-line Agilent HPLC instrumentation, UV spectrophotometers, atomic absorption spectrometers, and full microbial incubation chambers verifying each batch prior to dispatch.
Essential operational details regarding shipping terms, shelf life, documentation, and customization.
Inquire today for full batch COAs, specialized ocean freight quotations to Majuro, formulation compatibility dossiers, or complimentary laboratory trial samples.